Ownership history in Bruce & Co., Inc. · 53 quarters on record
This page tracks every 13F SEC filing in which Bruce & Co., Inc. reported a position in Abbvie Common (ABBV). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 122,500 | -5,000 | -3.9% | 8.68% | $28.0M | $226.67 |
| 2025 Q3 | UNCHANGED | 127,500 | — | 0% | 9.14% | $29.5M | $228.05 |
| 2025 Q2 | UNCHANGED | 127,500 | — | 0% | 7.67% | $23.7M | $181.25 |
| 2025 Q1 | REDUCED | 127,500 | -10,000 | -7.3% | 8.57% | $26.7M | $202.72 |
| 2024 Q4 | REDUCED | 137,500 | -9,000 | -6.1% | 7.85% | $24.4M | $170.33 |
| 2024 Q3 | REDUCED | 146,500 | -15,000 | -9.3% | 8.42% | $28.9M | $187.79 |
| 2024 Q2 | ADDED | 161,500 | +23,500 | +17.0% | 9.11% | $27.7M | $161.62 |
| 2024 Q1 | UNCHANGED | 138,000 | — | 0% | 8.34% | $25.1M | $170.00 |
| 2023 Q4 | REDUCED | 138,000 | -25,000 | -15.3% | 7.46% | $21.4M | $143.30 |
| 2023 Q3 | REDUCED | 163,000 | -28,743 | -15.0% | 8.28% | $24.3M | $136.47 |
As of 2025 Q4 — sorted by position size